• 1
    Majeed A, Babb P, Jones J, Quinn M. Trends in prostate cancer incidence, mortality and survival in England and Wales 1971–98. BJU Int 2000; 85: 105862
  • 2
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985–1993. Int J Cancer 2002; 54: 594606
  • 3
    Nair B, Wilt T, MacDonald R, Rutks I. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. Cochrane Database Syst Rev; CD 003506
  • 4
    Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Int Med 1993; 118: 793803
  • 5
    Goldgar DE, Easton DF, Cannon-Albright LA et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 16008
  • 6
    Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991; 19: 4352
  • 7
    Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol. 1 and 2. Lyon: IARC 1987
  • 8
    Pharoah DP, Day NE, Duffy S, Easton DF, Ponder BAJ. Family history and risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71: 8009
  • 9
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986; 7: 17788
  • 10
    Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997 1998; 315: 62934
  • 11
    Morgani G, Gianferrari L, Cresseri A, Arrigoni G, Lovati G. Rechrches clinco-statistiques et genetiques sur les neoplasmies de la prostate. Acta Genet 1956; 6: 3045
  • 12
    Steele R, Lees REM, Kraus AS, Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chron Dis 1971; 24: 2937
  • 13
    Schuman LM, Mandel J, Blackard C, Bauer H, Scarlett J, Mchugh R. Epidemiologic study of prostatic cancer: Preliminary report. Cancer Treat Rep 1977; 61: 1816
  • 14
    Cannon L, Bishop DT, Skolnick M et al. Genetic epidemiology of prostate cancer in the Utah Mormon Geneology. Cancer Surveys 1982; 1: 4769
  • 15
    Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 33747
  • 16
    Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 13057
  • 17
    Whittemore AS, Wu AH, Kolonel LN et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Can Am J Epidemiol 1995; 141: 73240
  • 18
    Keetch DW, Rice JP, Suarez BK, Catalona WJ. Familial aspects of prostate cancer: a case control study. J Urol 1995; 154: 21002
  • 19
    Hayes RB, Liff JM, Pottern LM et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 1995; 60: 3614
  • 20
    Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995; 87: 9916
  • 21
    Lesko SM, Rosenberg L, Shapiro S. Family history and prostate cancer risk. Am J Epidemiol 1996; 144: 10417
  • 22
    Ghadirian P, Howe GR, Hislop TG, Maisonneuve P. Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer 1997; 70: 67981
  • 23
    Glover FE Jr, Coffey DS, Douglas LL et al. Familial study of prostate cancer in Jamaica. Urology 1998; 52: 4413
  • 24
    Bratt O, Kristoffersson U, Lundgren R, Olsson H. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 1999; 35: 2727
  • 25
    Hemminki K, Czene K. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 2002; 95: 134653
  • 26
    Hemminki K, Dong C. Familial prostate cancer from the family-cancer database. Eur J Cancer 2000; 36: 22934
  • 27
    Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974; 3: 1549
  • 28
    Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13: 73944
  • 29
    Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. The Prostate 1985; 6: 1218
  • 30
    Gronberg H, Damber L, Damber JE. Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 1996; 77: 13843
  • 31
    Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 7885
  • 32
    Smith JR, Freije D, Carpten JD et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996; 274: 13714
  • 33
    Valeri E, Drelon T, Paiss W et al. Genetic analysis of familial prostatic cancer: localisation of a gene predisposing to prostate cancer (PCaP) on chromosome 1q42.2–43. Prog Urol 1999; 9: 6808
  • 34
    Xu J, Meyers D, Freije D et al. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998; 20: 1759
  • 35
    Gibbs M, Stanford JL, McIndoe RA et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999; 64: 77687
  • 36
    Bock CH, Cunningham JM, McDonnell SK et al. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am J Hum Genet 2001; 68: 795801
  • 37
    Tavtigian SV, Simard J, Teng DHF, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nature Genet 2001; 27: 17280
  • 38
    Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nature Genet 1995; 9: 24955
  • 39
    Cancel-Tassin G, Latil A, Valeri A et al. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. Eur J Hum Genet 2001; 9: 13542
  • 40
    McIndoe RA, Stanford JL, Gibbs M et al. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24–25. Am J Hum Genet 1997; 61: 34753
  • 41
    Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci U S A 1992; 89: 336771
  • 42
    Gronberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 1997; 146: 5527
  • 43
    Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. Segregation analyses of 1476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001; 68: 120718
  • 44
    Rokman A, Ikonen T, Seppala EH et al. Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 2002; 70: 1299304
  • 45
    Gong G, Oakley-Girvan I, Wu AH et al. Segregation analysis of prostate cancer in 1,719 white African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002; 13: 47182
  • 46
    Ellison L, Cheli C, Bright S, Veltri R, Partin A. Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening. Urology 2002; 60: 42
  • 47
    Hall RR. Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against. Eur Urol 1996; 29 (Suppl. 2): 246
  • 48
    Hanus MC, Zagars GK, Pollack A. Familial prostate cancer: outcome following radiation therapy with or without adjuvant androgen ablation. Int J Radiat Oncol Biol Phys 1999; 43: 37983
  • 49
    Gronberg H, Damber L, Tavelin B, Damber JE. No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol 1998; 82: 5647
  • 50
    Bauer JJ, Srivastava S, Connelly RR et al. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology 1998; 51: 9706
  • 51
    Valeri A, Azzouzi R, Drelon E et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 2000; 45: 6671